SMS Pharmaceuticals reported a 2.05% increase in consolidated net profit to ₹20.91 crore for the quarter ended June 2026, compared to ₹20.49 crore in the corresponding quarter of the previous year. According to reports from Business Standard, the pharmaceutical company demonstrated steady growth in its financial performance during the first quarter of fiscal year 2026. The company's diluted normalized EPS increased by 18.46% to ₹2.31 from ₹1.95 in the same period last year, indicating improved earnings per share performance.
The company's sales revenue increased by 5.56% to ₹206.96 crore in Q1 FY2026, up from ₹196.05 crore recorded in the same quarter of the previous financial year. As reported by Business Standard, this revenue growth indicates improved business operations and market demand for the company's pharmaceutical products during the quarter. However, the company's total revenue declined by 21.01% to ₹237.95 crore in Q1 FY2026 compared to ₹164.45 crore in the corresponding quarter of the previous year, reflecting the impact of seasonal variations and market conditions.
The company demonstrated effective cost management with total operating expenses decreasing by 22.96% to ₹166.43 crore in Q1 FY2026 from ₹208.18 crore in the corresponding quarter of the previous year. According to the latest financial data, selling, general and administrative expenses decreased by 31.71% to ₹18.18 crore from ₹29.47 crore year-on-year. This significant reduction in operational costs contributed to the company's improved profitability metrics despite the revenue decline on a quarter-on-quarter basis.
The company's operating profit margin (OPM) stood at 19.79% in the June 2026 quarter, compared to 20.08% in the corresponding quarter of the previous year. According to the financial data, the company's PBDT (Profit Before Depreciation and Tax) increased by 9% to ₹37.20 crore from ₹34.12 crore year-on-year. Additionally, PBT (Profit Before Tax) rose by 12% to ₹27.21 crore from ₹24.37 crore in the same period last year. The company's net income before taxes increased by 11.63% to ₹27.07 crore from ₹24.37 crore in the corresponding quarter of the previous year.
